Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
19.45
-0.05 (-0.26%)
At close: Dec 20, 2024, 4:00 PM
19.32
-0.13 (-0.67%)
After-hours: Dec 20, 2024, 4:24 PM EST

Arrowhead Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for ARWR stock have an average target of 42.7, with a low estimate of 24 and a high estimate of 80. The average target predicts an increase of 119.54% from the current stock price of 19.45.

Analyst Consensus: Buy
Target Low Average Median High
Price $24 $42.7 $42 $80
Change +23.39% +119.54% +115.94% +311.31%

Analyst Ratings

The average analyst rating for ARWR stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 344444
Buy 223444
Hold 333344
Sell 000000
Strong Sell 000000
Total 8910111212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$80
Strong Buy Reiterates $80 +311.31% Dec 20, 2024
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$60
Strong Buy Maintains $60 +208.48% Dec 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$60$80
Strong Buy Maintains $60$80 +311.31% Dec 3, 2024
Bernstein
Bernstein
Hold
Maintains
$27$24
Hold Maintains $27$24 +23.39% Nov 29, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$62$45
Buy Maintains $62$45 +131.36% Nov 27, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
153.59M
from 3.55M
Increased by 4,225.26%
Revenue Next Year
244.95M
from 153.59M
Increased by 59.48%
EPS This Year
-4.31
from -5.00
EPS Next Year
-3.79
from -4.31
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Sep 30, 2020 Sep 30, 2021 Sep 30, 2022 Sep 30, 2023 Sep 30, 2024 Sep 30, 2025 Sep 30, 2026 Sep 30, 2027
Revenue
87.99M138.29M243.23M240.74M3.55M153.59M244.95M393.64M
Revenue Growth
-47.87%57.16%75.89%-1.03%-98.52%4,225.26%59.48%60.70%
EPS
-0.84-1.36-1.67-1.92-5.00-4.31-3.79-2.46
EPS Growth
--------
Forward PE
--------
No. Analysts -----18149
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 464.8M 423.2M 990.4M
Avg 153.6M 245.0M 393.6M
Low n/a 111.4M 84.6M

Revenue Growth

Revenue Growth 20252026202720282029
High
12,990.4%
175.5%
304.3%
Avg
4,225.3%
59.5%
60.7%
Low -
-27.4%
-65.5%

EPS Forecast

EPS 20252026202720282029
High -1.85 -1.49 1.86
Avg -4.31 -3.79 -2.46
Low -6.16 -5.78 -4.26

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.